Elanco Misled Investors About Dog Medicine Safety, Suit Says <https://www.law360.com/health/articles/1887718?nl_pk=6422bbc2-a823-4be5-9a9f-132770eb1771&utm_source=newsletter&utm_medium=email&utm_campaign=health&utm_content=2024-10-09&read_main=1&nlsidx=0&nlaidx=12> By Rae Ann Varona An Elanco investor lodged a proposed securities class action against the animal pharmaceutics company on Monday, telling a Maryland federal court that the company misled investors about the safety of a canine dermatitis treatment it was developing and its timelines for drug launches. Complaint attached | Read full article » <https://www.law360.com/health/articles/1887718?nl_pk=6422bbc2-a823-4be5-9a9f-132770eb1771&utm_source=newsletter&utm_medium=email&utm_campaign=health&utm_content=2024-10-09&read_more=1&nlsidx=0&nlaidx=12> | Save to favorites » <https://www.law360.com/health/articles/1887718?nl_pk=6422bbc2-a823-4be5-9a9f-132770eb1771&utm_source=newsletter&utm_medium=email&utm_campaign=health&utm_content=2024-10-09&read_later=1&nlsidx=0&nlaidx=12>